Tuberculosis: an overview of current literature on types, diagnosis and drug therapy

Authors

  • Victor Prabhakar D. Department of Pharmacy Practice, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, Andhra Pradesh, India
  • Lakshmi Keerthana R. Department of Pharmacy Practice, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, Andhra Pradesh, India
  • Shaik Salma Department of Pharmacy Practice, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, Andhra Pradesh, India
  • Amreen Siddiqua A. Department of Pharmacy Practice, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, Andhra Pradesh, India
  • Meghana Suryadevara Department of Pharmacy Practice, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, Andhra Pradesh, India
  • Naveen Babu Kilaru Department of Pharmaceutics and Pharmaceutical Biotechnology, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, Andhra Pradesh, India
  • Ravindrababu Pingili Department of Pharmacology, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, Andhra Pradesh, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20192939

Keywords:

Drug resistance, Drug therapy, Isoniazide, Mycobacterium tuberculosis, Rifampicin, Tuberculosis

Abstract

Tuberculosis (TB) is an airborne infectious disease caused by organisms of the Mycobacterium tuberculosis complex. It is a global problem and increases in case rates are occurring not only in the developing countries of the world but also in several industrialized nations. There has also been an alarming increase in the number and proportion of cases caused by strains of Mycobacterium tuberculosis that are resistant to multiple first-line drugs. The increase in multiple-drug resistant tuberculosis has re-taught physicians about the importance of pursuing and ensuring treatment until cure. In many low-income and middle-income countries, TB continues to be a major cause of morbidity and mortality, and drug-resistant TB is a major concern in many settings. This article offers an overview of types, diagnosis and management of TB.

References

World Health Organization. Global tuberculosis report 2013. p. 1-145. Available at: http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf

New York State Department of Health Bureau of Tuberculosis Control; 2014. Available at: http://www.nejm.org/doi/full/10.1056/NEJMp1402147

WHO. Global Tuberculosis Control. Geneva; 2015. Available at: https://apps.who.int/iris/handle/10665/191102.

Surendra KS, Mohan A, Sharma A. Miliary tuberculosis: A new look at an old foe. J Clin Tubercul Mycobacterial Dis. 2016;3(5):13-27.

Kulchavenya E, Naber K, Bjerklund TEJ. Urogenital Tuberculosis: Classification, Diagnosis, and Treatment. Eur Urol Suppl. 2016;15(4):112-21.

Chang HC, Yu MC, Chih WL, Yu JC, Chun YC, Jui KH. Early diagnosis of spinal tuberculosis. J Formosan Med Asso. 2016;115(10):825-36.

Cary C, Jhajj M, Cinicola J, Evans R, Cheriyath P, Subhash VG. A rare case of fibrostenotic endobronchial tuberculosis of trachea. Ann Med Surg. 2015;4(4):479-82.

Pravin R, Gambhire P. Abdominal Tuberculosis. J Assoc Phys India. 2016;64:8-47.

Gonzalez MJ, Jose MGG, Anibarro L, Vidal R, Esteban J, Blanquer R, et al. Consensus Document on the Diagnosis, Treatment and Prevention of Tuberculosis. Archivos de Bronconeumologia. 2010;46(5):255-74.

Richard DB. Clinical tuberculosis. Med. 2016;44(6):384-89.

Agashe V, Ganesh M, Shubhadha S, Rodrigues C. Osteoarticular tuberculosis-Diagnostic solutions in a disease endemic region. J Infec Develop Countries. 2009;3(7):511-6.

Shourya H, Rithesh KB, Baroudi K, Umar D. Tuberculous Lymphadenitis: Early Diagnosis and Intervention. J Int Oral Health. 2014;6(6):96-8.

Yencha MW, Linfesty R, Blackmon A. Laryngeal tuberculosis. Am J Otolaryngol. 2000;21(2):122-6.

Belo DSJ, Roberta FA, Elise FC, Helena DOM, Gomes DSP, Sileira DMVL. Cutaneous tuberculosis: diagnosis, histopathology and treatment - Part II. Anais Brasileiros de Dermatologia. 2014;89(4):545-55.

Musteikiene G, Miliauskas S, Sakalauskas R, Vitkauskiene A, Zemaitis M. Multidrug-resistant tuberculosis in Lithuania-Still a long way ahead. Medicina (Kaunas). 2016;52(2):69-78.

Suhail A, Mokaddas E. Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis. J Infect Public Health. 2014;7(2):75-91.

Soumya S, Natarajan PA, Sundaramurthi JC, Sujatha N. Recent developments in genomics, bioinformatics and drug discovery to combat emerging drug-resistant tuberculosis. Tuberculosis (Edinburgh, Scotland) 2016;101:31-40.

Downloads

Published

2019-06-28

How to Cite

D., V. P., R., L. K., Salma, S., A., A. S., Suryadevara, M., Kilaru, N. B., & Pingili, R. (2019). Tuberculosis: an overview of current literature on types, diagnosis and drug therapy. International Journal of Research in Medical Sciences, 7(7), 2875–2882. https://doi.org/10.18203/2320-6012.ijrms20192939

Issue

Section

Review Articles